Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Lab Tests Of H1N1 Samples In Region Could Predict World Spread

This article was originally published in PharmAsia News

Executive Summary

An Australian laboratory may hold the key to an accurate judgment of the spread and possible mutation of the H1N1 virus in the Asia-Pacific area. The Anne Kelso Laboratory in Melbourne is collecting virus samples from around the region and could be able to indicate the size and strength of a new round of infections expected in Europe and North America later this year. Of immediate interest is whether the virus is developing resistance to Roche's Tamiflu (oseltamivir). (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel